Search clinical trials for: Nonsteroidal Aromatase Inhibitor (NSAI)
Total 2550 results
-
Boehringer IngelheimCompleted
-
Memorial Sloan Kettering Cancer CenterVerastem, Inc.RecruitingLow-Grade Serous Ovarian CancerUnited States
-
Genor Biopharma Co., Ltd.Recruiting
-
Fujian Medical University Union HospitalNot yet recruitingAdvanced Breast Cancer
-
PfizerAstellas Pharma Inc; Medivation, Inc.Active, not recruitingBreast CancerUnited States, Spain, Belgium, Canada, Italy, Ireland, United Kingdom
-
Novartis PharmaceuticalsActive, not recruitingBreast CancerUnited States, South Africa, Austria, Hungary, Germany, Czechia, France, Russian Federation, Thailand, Belgium, Bulgaria, Lithuania, Jordan, Sweden, Finland, Peru, Colombia, Portugal, Canada, Brazil, India, Argentina, Costa Rica
-
Eli Lilly and CompanyActive, not recruitingBreast CancerCanada, Germany, Australia, Japan, United States, Taiwan, Belgium, New Zealand, Italy, Israel, Spain, France, Netherlands, Mexico, Turkey, United Kingdom, Korea, Republic of, Austria, Puerto Rico, Sweden, Russian Federation, Greece, Slovaki...
-
Duke UniversityActive, not recruitingMetastatic Breast Cancer | Locally Advanced Breast Cancer | Hormone Receptor Positive TumorUnited States
-
MedSIRCellestia Biotech AGTerminated
-
Chipscreen Biosciences, Ltd.Completed
-
Stanford UniversityCompleted
-
Guangdong Provincial People's HospitalCompletedHighly Endocrine Responsive Operable Breast CancerChina
-
NYU Langone HealthNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Sinai Hospital of BaltimoreUnknownOvarian Cancer | Endometrial CancerUnited States
-
The Affiliated Hospital of Qingdao UniversityJiangsu HengRui Medicine Co., Ltd.Not yet recruiting
-
Fudan UniversityRecruitingEndometrial CancerChina
-
Centre Leon BerardRecruitingLow Grade Endometrial Stromal SarcomaFrance
-
Eisai Co., Ltd.Active, not recruiting
-
SOLTI Breast Cancer Research GroupDaiichi Sankyo, Inc.Active, not recruiting
-
Canadian Cancer Trials GroupAlliance for Clinical Trials in Oncology; Eastern Cooperative Oncology Group; North Central Cancer Treatment Group and other collaboratorsCompletedBreast CancerCanada, United Kingdom
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology Group; Cancer and... and other collaboratorsCompleted
-
Spanish Breast Cancer Research GroupPfizerCompleted
-
Qamar KhanNovartis PharmaceuticalsActive, not recruiting
-
Novartis PharmaceuticalsCompleted
-
Cairo UniversityUnknownBreast Cancer | Metastatic Breast Cancer | Estrogen Receptor-positive Breast CancerEgypt
-
Greater Baltimore Medical CenterCompleted
-
Beth Israel Deaconess Medical CenterAstraZenecaCompletedErectile Dysfunction | Hypogonadism | Seizure DisorderUnited States
-
Cancer Institute and Hospital, Chinese Academy...Unknown
-
Cairo UniversityUnknown
-
PfizerTerminatedEarly Breast Cancer (Phase 2) | Advanced Breast Cancer (Phase 1b)Spain, Sweden, Italy, Belgium
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)WithdrawnBreast CancerUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)Withdrawn
-
Dr. Reddy's Laboratories LimitedCompleted
-
Novartis PharmaceuticalsRoche - Prof. Dr. Jens Huober et al.TerminatedMetastatic Breast CancerGermany
-
Korean Breast Cancer Study GroupUnknownBreast CancerKorea, Republic of
-
University of California, San FranciscoNational Cancer Institute (NCI)CompletedBreast Cancer | Fatigue | Neurotoxicity | Cognitive/Functional Effects | Psychosocial Effects of Cancer and Its Treatment | Long-term Effects Secondary to Cancer Therapy in Adults | Chemotherapeutic Agent ToxicityUnited States
-
Jonsson Comprehensive Cancer CenterBayer; Translational Research in Oncology-U.S. Inc. (TRIO-US)TerminatedStage I Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Invasive Breast Carcinoma | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | HER2/Neu Negative and other conditionsUnited States
-
Centre Hospitalier Universitaire, AmiensUniversity Hospital, Rouen; University Hospital, LilleRecruitingCardiac Surgery | Acute Postoperative Pain | Pain Intensity | Multimodal Pain Management | Non-steroidal Anti-inflammatory DrugsFrance
-
Dompé Farmaceutici S.p.ACompletedAcute PainRussian Federation
-
Novartis PharmaceuticalsCompleted
-
Boehringer IngelheimCompletedBreast NeoplasmsSpain, United States, Belgium, Italy, Germany, France, Greece, United Kingdom, Portugal, Australia, Canada
-
SOLTI Breast Cancer Research GroupPfizerCompleted
-
Dana-Farber Cancer InstitutePfizerCompletedHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone Receptor (HR)-Positive Breast CancerUnited States
-
Syndax PharmaceuticalsCompletedBreast Cancer | ER+ Breast Cancer | Estrogen Receptor-Positive Breast Cancer | Breast Cancer, Estrogen Receptor-PositiveUnited States, Czechia, Canada, Hungary, Russian Federation
-
AstraZenecaCompletedBreast CancerUnited States, Mexico, Venezuela, Colombia
-
Bristol-Myers SquibbCompletedBreast CancerCzech Republic, United States, Spain, United Kingdom, Ireland, Poland, France, Sweden
-
Eli Lilly and CompanyMerck Sharp & Dohme LLCActive, not recruitingBreast Cancer | Non Small Cell Lung CancerUnited States, Spain, France, Belgium, Italy, Taiwan, Turkey
-
Latin American Cooperative Oncology GroupPfizerCompleted
-
Baylor Breast Care CenterGlaxoSmithKline; Translational Breast Cancer Research ConsortiumActive, not recruitingBreast CancerUnited States